Gossamer Bio(GOSS) - 2020 Q4 - Earnings Call Transcript

Gossamer Bio, Inc. (NASDAQ:GOSS) Q4 2020 Earnings Conference Call February 25, 2021 8:30 AM ET Company Participants Bryan Giraudo - CFO Faheem Hasnain - Co-Founder, CEO, & Chairman Richard Aranda - SVP, Clinical Development Conference Call Participants Unidentified Analyst - Carter Gould - Barclays Bank Emma Nealon - Cantor Fitzgerald & Co. Olivia Brayer - Bank of America Securities Patrick Trucchio - H.C. Wainwright & Co Unidentified Analyst - SMBC Operator Ladies and gentlemen, thank you for standing ...